[1]
E. Pavlovschi, V. Pantea, D. Borovic, and O. Tagadiuc, “Study of ischemia modified albumin (IMA) as a biomarker in hypertensive retinopathy”, Med Pharm Rep, vol. 94, no. 2, pp. 185–190, Apr. 2021.